alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Tennessee Valley Authority

# FOR MORE INFORMATION CONTACT:

Please call TVA Media Relations at (865) 632-6000, Knoxville, Tennessee. Information is also available at TVA's Washington Office (202) 898-2999. People who plan to attend the meeting and have special needs should call (865) 632-6000.

Dated: June 4, 2001.

Maureen H. Dunn,

General Counsel and Secretary.

[FR Doc. 01-14446  Filed 6-5-01; 10:30 am]

BILLING CODE 8120-08-M
Exhibit 31-2
 CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
      a)
    
    designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the Registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this Report is being prepared;
 b)
    
    designed such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
 c)
    
    evaluated the effectiveness of the Registrants disclosure controls and
procedures and presented in this Report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this Report
based on such evaluation; and
 d)
    
    disclosed in this Report any change in the Registrants internal control over
financial reporting that occurred during the Registrants most recent fiscal quarter
(the Registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the Registrants
internal control over financial reporting; and
  a)
    
    all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably likely to
adversely affect the Registrants ability to record, process, summarize and report
financial information; and
 b)
    
    any fraud, whether or not material, that involves management or other
employees who have a significant role in the Registrants internal control over
financial reporting.
 Date: September 24, 2010
    
    By:
    
    /s/ William McDonald

William McDonald,CFO
EXHIBIT 32.2



Section 1350 Certification



In connection with the Annual Report of
Innovus Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2012, as filed with
the Securities and Exchange Commission (the “Report”), I, Vivian Liu, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:



|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
|-- | ---------------------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



|August 3, 2012 |  | /s/Vivian Liu,                     
|-------------- |  | -----------------------------------
|               |  | Vivian Liu, Chief Financial Officer
```

[Federal Register: April 25, 2000 (Volume 65, Number 80)]
[Notices]
[Page 24186]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25ap00-48]

=======================================================================
-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIME AND DATE: 11:00 a.m., Friday, May 5, 2000.

PLACE: 1155 21st St., NW., Washington, DC, 9th Floor Conference Room.

STATUS: Closed.

MATTER TO BE CONSIDERED: Surveillance Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 00-10346 Filed 4-21-00; 11:32 am]
BILLING CODE 6351-01-M
```

----

**======== RETURN TO INDEX    ========**

----
```

[Federal Register: March 3, 1998 (Volume 63, Number 41)]
[Notices]
[Page 10364]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03mr98-41]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIME AND DATE: 10:00 a.m., Thursday, March 5, 1998.

PLACE: 1155 21st St., N.W., Washington, D.C., 9th Fl. Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Adjudicatory Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.
Jean A. Webb,
Secretary of the Commission.
[FR Doc. 98-5618 Filed 2-27-98; 3:39 pm]
BILLING CODE 6351-01-M
```

----

**======== RETURN TO    INDEX ========**

----
Exhibit
31.1








CERTIFICATION
PURSUANT TO SECTION 302


OF
THE SARBANES-OXLEY ACT OF 2002





I,
Allan Reeh, Chief Executive and Chief Financial Officer of LG Holding
Corporation, certify that:





1.   I
have reviewed this quarterly report on Form 10-Q;





2.   Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this;





3.   Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the small business issuer as
of, and for, the periods presented in this report;





4.   I
am responsible for establishing and maintaining disclosure controls and
procedures as defined in Exchange Act Rules 13a-15(e) and 15d-a5(e)) for the
small business issuer and have;





(a)  Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure the material
information relating to the small business issuer, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;





(b)  Evaluated
the effectiveness of the small business issuer's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation





(c)  Disclosed
in this report any change in the small business issuer's internal control over
financial reporting that occurred during the small business issuer's most recent
fiscal quarter (the small business issuer's fourth fiscal quarter in the case of
an annual report) that has materially affected, or is reasonably likely to
materially affect, the small business issuer's internal control over financial
reporting; and





5. I have
disclosed, based on my most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
the small business issuer's board of directors (or person performing the
equivalent functions);





(a)  All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the small business issuer's ability to record, process
summarize and report financial information; and





(b)  Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the small business issuer's internal controls over
financial reporting.





Dated:
August 28, 2008




By:
            /s/ Allan ReehAllan
      Reeh
              Chief
      Executive Officer
              Chief
      Financial Officer
```

[Federal Register: July 8, 1998 (Volume 63, Number 130)]
[Notices]
[Page 36883]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08jy98-52]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

TIME AND PLACE: 2:00 p.m., Wednesday, July 29, 1998.

PLACE: 1155 21st St., N.W., Washington, D.C., 9th Floor Conference
Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Enforcement Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.
Jean A Webb,
Secretary of the Commission.
[FR Doc. 98-18249 Filed 7-6-98; 2:22 p.m.]
BILLING CODE 6351-01-M
```

----

**======== RETURN TO INDEX    ========**

----
This opinion is subject to administrative correction before final disposition.

Before HITESMAN, CRISFIELD, and GEIS , Appellate Military Judges

_________________________ 

### UNITED STATES Appellee

v. Wilmer VASQUEZ Corporal (E

- 4 ), U.S. Marine Corps Appellant
No. 201900057
Decided: 29 August 2019

. Appeal from the United States Navy

- Marin e Corps Trial Judiciary

. Military Judge : Major Terrance J. Reese, USMC. Sentence adjudged 4 December 2018 by a speci al court

- martial convened at Marine Corps Base Camp Lejeune , North Carolina, consisting of a military judge sitting alone . Sentence approved by the convening authority: reduction to E

- 1, confinement for 135 days , 1 and a bad

- conduct discharge

. For Appellant: Lieutenant Commander Erin L. Alexander , JAGC, USN. For Appellee: Brian K. Keller, Esq.

_________________________ This opinion does not ser ve as binding precedent under NMCCA Rule of Appellate Procedure 30.2 (a)

.

_________________________

1 The Convening Authority suspe nded confinement in excess of 4 months pursuant to a pretrial agreement.United States v. Vasquez , No. 201 900057

2 PER CURIAM : After careful consideration of the record, submitted without assignment of error, we have determined that the approved findings and sentence are correct in law and fact and that no error materially prejudicial to the a ppellant’s substantial rights occurred. Articles 59 and 66, UCMJ, 10 U.S.C. §§ 859, 866. T he findings and sentence as approved by the convening authority are AFFIRMED

.
FOR THE COURT:

RODGER A. DREW, JR. Clerk of Court
```

[Federal Register: June 19, 2002 (Volume 67, Number 118)]
[Notices]
[Page 41698]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19jn02-37]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

Agency Holding the Meeting: Commodity Futures Trading Commission.

Time and Date: 11:00 a.m., Friday, July 19, 2002.

Place: 1155 21st St., NW., Washington, DC, 9th Floor Conference Room.

Status: Closed.

Matters to be Considered: Surveillance Matters.

Contact Person For More Information: Jean A. Webb, 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 02-15538 Filed 6-17-02; 9:10 am]
BILLING CODE 6351-01-M
```

�
Michigan Supreme Court

Lansing, Michigan

Marilyn Kelly,

 Chief Justice

Michael F. Cavanagh

Elizabeth A. Weaver

Maura D. Corrigan

Robert P. Young, Jr.

Stephen J. Markman

Diane M. Hathaway, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

July 26, 2010 

d0719 

Order 

 

July 26, 2010 

140900 

PEOPLE OF THE STATE OF MICHIGAN, 

Plaintiff-Appellee, 

v SC: 140900 

 COA: 288798 

Washtenaw CC: 08-000492-FC 

SHANNON FRENCH, 

Defendant-Appellant. 

_________________________________________/ 

 On order of the Court, the application for leave to appeal the February 16, 2010 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF COLUMBIA 

G. THOMAS PORTEOUS, JR., United ) 

States District Judge for the Eastern ) 

District of Louisiana, ) 

) 

Plaintiff, ) 

) 

v. ) Civil Case No. 09-2131 (RJL) 

) 

ALAN I. BARON, Special Counsel, ) 

Impeachment Task Force, Committee on ) 

the Judiciary, United States House of ) 

Representatives, et al., ) 

) 

Defendants. ) 

ORDER 

~ For the reasons set forth in the Memorandum Opinion entered this 2. day of 

August, 2010, it is hereby 

ORDERED that the Defendants' Motion to Dismiss [#7] is GRANTED; it is 

further 

ORDERED that PlaintiffG. Thomas Porteous, Jr.'s Motion for a Temporary 

Restraining Order and Preliminary Injunction [#2] is DENIED; and it is further 

ORDERED that the case is DISMISSED for lack of subject matter jurisdiction. 

SO ORDERED.
```

[Federal Register: June 16, 2003 (Volume 68, Number 115)]
[Notices]
[Page 35631]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16jn03-33]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meetings

TIME AND DATE: 11 a.m., Friday, June 20, 2003.

PLACE: 1155 21st St., NW., Washington, DC, 9th Floor Conference Room.

STATUS: Closed.

Matters To Be Considered: Surveillance Matters.

For Further Information Contact: Jean A. Webb, 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 03-15227 Filed 6-12-03; 8:45 am]
BILLING CODE 6351-01-M
```
[Federal Register Volume 66, Number 109 (Wednesday, June 6, 2001)]
[Notices]
[Page 30471]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-14162]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute, Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Training Grants.
    Date: June 27, 2001.
    Time: 6:00 PM to 7:30 PM.
    Agenda: To review and evaluate grant applications.
    Place: Chevy Chase Holiday Inn, 5520 Wisconsin Ave., Chevy 
Chase, MD 20815.
    Contact Person: Olivia Preble Bartlett, PhD, Chief, Grants 
Review Branch, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6116 Executive Boulevard, Room 8121, Rockville, MD 20892-
7405, 301/594-2501.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: May 30, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-14162 Filed 6-5-01; 8:45 am]
BILLING CODE 4140-01-M
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          26,050
<SECURITIES>                                         0
<RECEIVABLES>                                    8,124
<ALLOWANCES>                                     (476)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                39,974
<PP&E>                                           8,694
<DEPRECIATION>                                 (4,853)
<TOTAL-ASSETS>                                  45,106
<CURRENT-LIABILITIES>                           16,505
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            25
<OTHER-SE>                                      28,576
<TOTAL-LIABILITY-AND-EQUITY>                    45,106
<SALES>                                         36,258
<TOTAL-REVENUES>                                36,258
<CGS>                                            5,337
<TOTAL-COSTS>                                    5,337
<OTHER-EXPENSES>                                22,687
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  9,219
<INCOME-TAX>                                     3,226
<INCOME-CONTINUING>                              5,993
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,993
<EPS-PRIMARY>                                      .63
<EPS-DILUTED>                                      .56


</TABLE>
```

[Federal Register: February 18, 2003 (Volume 68, Number 32)]
[Notices]
[Page 7777]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18fe03-34]


-----------------------------------------------------------------------


COMMODITY FUTURES TRADING COMMISSION



Sunshine Act Meeting


Agency Holding the Meeting: Commodity Futures Trading Commission.


Time and Date: 2 p.m., Friday, March 7, 2003.


Place: 1155 21st St., NW., Washington, DC., 9th Floor Conference Room.


Status: Closed.


Matters to be Considered: Personnel Matters.


Contact Person for More Information: Jean A. Webb, 202-418-5100.


Jean A. Webb,
Secretary of the Commission.
[FR Doc. 03-3930 Filed 2-13-03; 11:18 am]
BILLING CODE 6351-01-M
```
EXHIBIT 31.1

                           CERTIFICATION PURSUANT TO
                 SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Fidel Thomas, President, Chief Executive Officer, Chief Financial Officer and
Principal Accounting Officer of Castmor Resources Ltd., certify that:

1.     I have reviewed this quarterly report on Form 10-Q of Castmor Resources
Ltd.;

2.     Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3.     Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4.     I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and I have:

a)     designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to me by others within those entities, particularly during the
period in which this quarterly report is being prepared;

b)     evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and

c)     presented in this quarterly report our conclusions about the
effectiveness of the disclosure controls and procedures based on my evaluation
as of the Evaluation Date;

5.     I have disclosed, based on our most recent evaluation, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent function):

a)     all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

b)     any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls.

6.     I have indicated in this quarterly report whether there were significant
changes in internal controls or in other factors that could significantly affect
internal controls subsequent to the date of my most recent evaluation, including
any corrective actions with regard to significant deficiencies and material
weaknesses.

Date: April 10, 2009


/s/ Fidel Thomas
Fidel Thomas
President, Chief Executive Officer,
Chief Financial Officer, and
Principal Accounting Officer
```

[Federal Register: November 17, 2006 (Volume 71, Number 222)]
[Notices]
[Page 66919]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17no06-39]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine act Meeting Notice

TIME AND DATE: 11 a.m., Friday, December 15, 2006.

PLACE: 1155 21st St., NW., Washington, DC, 9th Floor Commission
Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Enforcement Matters.

CONTACT PERSON FOR MORE INFORMATION: Eileen A. Donovan, 202-418-5100.

Eileen A. Donovan,
Acting Secretary of the Commission.
[FR Doc. 06-9286 Filed 11-15-06; 3:31 pm]

BILLING CODE 6351-01-M
```